[1N,12N]Bis(Ethyl)-cis-6,7-Dehydrospermine: a New Drug for Treatment and Prevention of Cryptosporidium parvum Infection of Mice Deficient in T-Cell Receptor Alpha

AUTOR(ES)

Waters, W. R.

FONTE

American Society for Microbiology

RESUMO

Cryptosporidium parvum infection of T-cell receptor alpha (TCR-α)-deficient mice results in a persistent infection. In this study, treatment with a polyamine analogue (SL-11047) prevented C. parvum infection in suckling TCR-α-deficient mice and cleared an existing infection in older mice. Treatment with putrescine, while capable of preventing infection, did not clear C. parvum from previously infected mice. These findings provide further evidence that polyamine metabolic pathways are targets for new anticryptosporidial chemotherapeutic agents.

Documentos Relacionados

• Cryptosporidium parvum infection in T-cell receptor (TCR)-alpha- and TCR-delta-deficient mice.
• Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta + cells.
• T-cell receptor genes in autoimmune mice: T-cell subsets have unexpected T-cell receptor gene programs.
• Increased Susceptibility of β7-Integrin-Deficient Neonatal Mice in the Early Stage of Cryptosporidium parvum Infection
• Expression of T-cell receptor alpha-chain genes in transgenic mice.